European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 9 February 2026 - 16:50

Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation: 27/05/2024, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 9 February 2026 - 16:46

Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation: 27/05/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Zypadhera, olanzapine, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 9 February 2026 - 15:25

Human medicines European public assessment report (EPAR): Zypadhera, olanzapine, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness